Table 2. Characteristics of the study population grouped according to the presence of the metabolic syndrome.

	No SM (N = 124)	SM (N = 46)	p
Age, years	50 ± 11	55 ± 10	0.010
Gender, % men	79	82	0.828
Race (Black/Hispanic-Latino), %	6/4	6/6	0.802
Current smoking, %	49	54	0.698
Body mass index, kg/m2	24.8 ± 4.2	28.6 ± 6.1	<0.001
Waist circumference, cm	91 ± 11	103 ± 14	<0.001
Systolic blood pressure, mmHg	124 ± 16	131 ± 15	0.013
Diastolic blood pressure, mmHg	77 ± 9	81 ± 9	0.026
Total cholesterol, mg/dL	194 ± 43	181 ± 41	0.107
LDL cholesterol, mg/dL	115 ± 35	99 ± 36	0.011
HDL cholesterol, mg/L	51 ± 11	40 ± 13	<0.001
Triglycerides, mg/dL	122 (87–167)	187 (159–250)	<0.001
Glucose, mg/mL	88 (82–95)	99 (88–122)	<0.001
CD4 cell count, n/μL	594 (436–764)	587 (393–856)	0.721
HIV-1 RNA level <400 copies/mL, %	94	100	0.191
Urine albumin to creatinine ratio, mg/g	9.7 (6.2–16.5)	22.2 (10.1–76.2)	<0.001
Brachial flow-mediated dilatation, %	6.1 (2.1–10.8)	3.9 (0.0–5.8)	<0.001